- Joined
- Oct 20, 2005
- Messages
- 16,923
- Reaction score
- 47,711
Well, it isn't approved yet, but it seems as if there is gonna be a new funding agency, for the time being housed within NIH, called ARPA-H (ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)):
It doesn't really have much structure to it at the moment, but it sounds like a joint non-profit/for-profit type of model like DARPA for competitions surrounding "high-risk, high-reward" innovations in biomedical science. Having done peer-review for DARPA, I imagine this would be similar in that the review aspects just give guidance about the project, but the project managers pick and choose as they see fit within the scope of what is the current "need".
It's an interesting idea to say the least. I get the sense that this is a little to "pie-in-the-sky" and people saw COVID and we like "hey, we created testing and a vaccine really fast, let's do that for everything" but don't quite realize how heterogenous human disease can be. But maybe people are willing to forego that for the next "breakthrough".
Theoretically, the program could start as early as 2022, but it's the government, so who know.
ARPA-H
Recent advances in biomedical science—from immunotherapy to treat cancer, to the highly effective COVID-19 vaccines—demonstrate the strengths and successes of the U.S. biomedical enterprise.
www.nih.gov
It doesn't really have much structure to it at the moment, but it sounds like a joint non-profit/for-profit type of model like DARPA for competitions surrounding "high-risk, high-reward" innovations in biomedical science. Having done peer-review for DARPA, I imagine this would be similar in that the review aspects just give guidance about the project, but the project managers pick and choose as they see fit within the scope of what is the current "need".
It's an interesting idea to say the least. I get the sense that this is a little to "pie-in-the-sky" and people saw COVID and we like "hey, we created testing and a vaccine really fast, let's do that for everything" but don't quite realize how heterogenous human disease can be. But maybe people are willing to forego that for the next "breakthrough".
Theoretically, the program could start as early as 2022, but it's the government, so who know.